Abnormalities of B Lymphocytes During Systemic Lupus

This study has been completed.
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
First received: November 16, 2006
Last updated: August 7, 2008
Last verified: August 2008
Previous experimental data strongly suggest that B lymphocytes have intrinsic abnormalities during lupus in mice spontaneously affected by the disease. This study tries to define these abnormalities by looking at the gene expression profile of purified B lymphocytes from patients with non active systemic lupus , compared with the gene expression profile of purified B lymphocytes from healthy donnors.

Condition Intervention
Systemic Lupus Erythematosus
Procedure: Blood samples

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Phenotypic Characteristics and Transcriptomas of B Lymphocytes During Non Active Systemic Lupus Erythematosus

Resource links provided by NLM:

Further study details as provided by University Hospital, Strasbourg, France:

Estimated Enrollment: 30
Study Start Date: April 2004

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion criteria:

  • non active systemic lupus

Exclusion criteria:

  • immunosuppressive drugs
  • more than 10 mg of prednisone per day
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00401141

Service d'Immunologie Clinique et VIH - Hôpital Civil
Strasbourg, France, 67091
Sponsors and Collaborators
University Hospital, Strasbourg, France
Study Director: Jean-Louis Pasquali, MD Hôpitaux Universitaires de Strasbourg
  More Information

ClinicalTrials.gov Identifier: NCT00401141     History of Changes
Other Study ID Numbers: 3156 
Study First Received: November 16, 2006
Last Updated: August 7, 2008
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Strasbourg, France:
Systemic lupus
B lymphocytes

Additional relevant MeSH terms:
Lupus Erythematosus, Systemic
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on May 25, 2016